Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer

NCT00806156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor
Ovarian Cancer

Interventions

DRUG: NKTR-102 q14d
DRUG: NKTR-102 q21d

Sponsor

Nektar Therapeutics